Publication|Articles|March 14, 2025
- Pharmaceutical Executive: March 2025
- Volume 45
- Issue 2
Pharmaceutical Executive: March 2025 Interactive Digital Edition
View the Pharmaceutical Executive March 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 year ago
High Impactabout 1 year ago
Mark Frohlich: A ‘Natural’ Leaderabout 1 year ago
FDA’s New Accelerated Approval Draft Guidanceabout 1 year ago
The Virtual Reality of Modern Pharma Sales and MarketingNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
2
Teva Enters $900 Million Agreement to Acquire Emalex
3
Pharmaceutical Risks in the Strait of Hormuz
4
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
5
